Growth Metrics

Zimmer Biomet Holdings (ZBH) Accounts Payables (2016 - 2026)

Zimmer Biomet Holdings has reported Accounts Payables over the past 18 years, most recently at $361.2 million for Q1 2026.

  • For Q1 2026, Accounts Payables rose 19.88% year-over-year to $361.2 million; the TTM value through Mar 2026 reached $361.2 million, up 19.88%, while the annual FY2025 figure was $303.0 million, 55.7% up from the prior year.
  • Accounts Payables for Q1 2026 was $361.2 million at Zimmer Biomet Holdings, up from $303.0 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $410.6 million in Q4 2023 and troughed at $194.6 million in Q4 2024.
  • A 5-year average of $332.8 million and a median of $333.9 million in 2022 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: tumbled 52.61% in 2024 and later soared 55.7% in 2025.
  • Year by year, Accounts Payables stood at $354.1 million in 2022, then increased by 15.96% to $410.6 million in 2023, then tumbled by 52.61% to $194.6 million in 2024, then surged by 55.7% to $303.0 million in 2025, then grew by 19.21% to $361.2 million in 2026.
  • Business Quant data shows Accounts Payables for ZBH at $361.2 million in Q1 2026, $303.0 million in Q4 2025, and $315.3 million in Q3 2025.